20 November 2025
Sodium Valproate Monitoring Statistics: April 2019 to September 2025 and Topiramate Monitoring Statistics: April 2023 to September 2025 have been published as part of the General Pharmaceutical Services and Prescribing Statistics for Northern Ireland publication schedule.
These reports, produced in accordance with the Code of Practice for Statistics, contribute to the monitoring of the effectiveness of actions to ensure safe and appropriate use of prescribed Sodium Valproate and Topiramate in Northern Ireland.
Both reports can be accessed on the BSO website by clicking on the following link: Sodium Valproate & Topiramate Monitoring – Business Services Organisation (BSO) Website
The Sodium Valproate Monitoring Dashboard, published for the first time in November 2025, presents the figures of the five indicators contained within the published tables in interactive visuals. Replacing the charts that had previously been published within this report, this interactive dashboard allows users to easily select between numerous variables in order to focus on specific areas of interest, such as age group, gender or area in each of the five indicators. This can be accessed at the following link: https://datavis.nisra.gov.uk/bso/sodium-valproate-monitoring-dashboard.html
An infographic summary of the main findings of each report is below.
Please note: The current Topiramate publication contains a revision, following identification of an error contained in indicator 3 (rate per 1,000 population). Any tables and charts affected by this revision are denoted by (R). Users should therefore not use previous editions of this report. For more information, please see the introductory notes within the current report.
